CL
GSK icon

COWA LLC’s GSK GSK Stock Holding History

COWA LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Hold
4,009
– – 0.05% 178
2026
Q1 		$221K Buy
+4,009
New +$217K 0.06% 146
2022
Q4 		– Sell
-831
Closed -$24K – 203
2022
Q3 		$24K Buy
+831
New +$31.5K 0.02% 236
2021
Q2 		– Sell
-1,071
Closed -$49K – 211
2021
Q1 		$49K Buy
1,071
+159
+17% +$7.22K 0.03% 202
2020
Q4 		$43K Buy
+912
New +$41.9K 0.03% 210

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

COWA LLC's GSK Position: Q2 2026 in Review

COWA LLC held its GSK (GSK) position steady in Q2 2026 at 4,009 shares worth $210K. The position accounts for 0.05% of the portfolio, ranked #178.

COWA LLC first reported a position in GSK in Q4 2020 and has held it in 5 quarters since. The position peaked at $221K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • COWA LLC held 4,009 shares of GSK worth $210K as of Q2 2026.
  • COWA LLC left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.05% of COWA LLC's portfolio in Q2 2026, its #178 holding.
  • COWA LLC first reported a position in GSK in Q4 2020 and has held it in 5 quarters since.
  • COWA LLC's GSK position peaked at $221K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on COWA LLC's 13F filing for Q2 2026, filed 6 Aug 2026.